Deerfield Management’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Deerfield Management’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-572,893	Closed	-$1.2M	–	117
2016 Q4	$1.2M	Hold	572,893	–	–	0.05%	99
2016 Q3	$1.51M	Hold	572,893	–	–	0.07%	82
2016 Q2	$1.09M	Buy	572,893 +497,600	+661%	+$1.31M	0.04%	96
2016 Q1	$221K	Buy	+75,293	New	+$215K	0.01%	104
2015 Q1	–	Sell	-461,119	Closed	-$2.94M	–	139
2014 Q4	$2.94M	Hold	461,119	–	–	0.11%	91
2014 Q3	$2.26M	Buy	461,119 +200,000	+77%	+$1.15M	0.08%	111
2014 Q2	$2M	Hold	261,119	–	–	0.08%	104
2014 Q1	$2.75M	Buy	261,119 +50,000	+24%	+$715K	0.11%	106
2013 Q4	$2.74M	Buy	+211,119	New	+$1.97M	0.14%	84

Other funds holding OCRX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deerfield Management's OCRX Position: Q1 2017 in Review

Deerfield Management sold out of Ocera Therapeutics, Inc. (OCRX) in Q1 2017, closing a stake of 572,893 shares — an estimated $1.2M sold.

Deerfield Management first reported a position in OCRX in Q4 2013 and held it in 9 quarters. The position peaked at $2.94M in Q4 2014. 26 funds tracked by Wall St. Rank hold OCRX as of Q1 2017.

Deerfield Management reported no remaining Ocera Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
Deerfield Management sold 572,893 Ocera Therapeutics, Inc. shares in Q1 2017, an estimated $1.2M.
Deerfield Management first reported a position in Ocera Therapeutics, Inc. in Q4 2013 and held it in 9 quarters.
Deerfield Management's Ocera Therapeutics, Inc. position peaked at $2.94M in Q4 2014.
26 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q1 2017.

Based on Deerfield Management's 13F filing for Q1 2017, filed 15 May 2017.